Syllabus
BCGP Prep Course (BCGP)
74 lessons. Online and self-paced.
Aging Patient Assessment
Core physiologic, functional, cognitive, and social assessment concepts that shape medication decisions in older adults. Emphasis is placed on recognizing geriatric syndromes, multimorbidity, and care-setting factors that alter pharmacotherapy risk and benefit.
- 1Age-Related PK Changes
- 2Age-Related PD Changes
- 3Pathophysiology In Older Adults
- 4Frailty And Prognosis
- 5Falls Delirium And Incontinence
- 6ADL IADL Interpretation
- 7Cognitive Change And Dementia
- 8Depression Anxiety And Sleep
- 9Caregiver Burden And Resources
- 10Abuse Neglect And Isolation
Treatment Planning Frameworks
Structured approaches to clinical assessment, diagnostic interpretation, shared decision-making, and individualized therapeutic goal setting for older adults.
- 11Medication History Essentials
- 12Lab Vital And Symptom Review
- 13Diagnostic Testing Interpretation
- 14Shared Decision-Making Principles
- 15Time To Benefit Logic
- 16Social Determinants And Feasibility
- 17Guideline Concordance In Geriatrics
- 18Pharmacogenomics Relevance
- 19Prioritizing Medication Problems
Medication Review Optimization
Comprehensive medication review methods for identifying inappropriate therapy, reducing polypharmacy, and implementing safer regimens in older adults.
- 20Beers Criteria Use
- 21STOPP START And FORTA
- 22Tool Limitations And Judgment
- 23Polypharmacy Risk Stratification
- 24Prescribing Cascade Recognition
- 25Deprescribing Taper Strategies
- 26Dosage Form Feasibility
- 27Devices And Administration Technique
- 28Education For Patients And Caregivers
Cardiometabolic Therapeutics
High-yield geriatric pharmacotherapy principles for common cardiometabolic conditions, emphasizing individualized targets, adverse effects, and deprescribing decisions.
- 29Hypertension Targets In Older Adults
- 30Heart Failure Medication Decisions
- 31Antiplatelet And Antianginal Safety
- 32DOAC And Warfarin Selection
- 33Bleeding Risk And Monitoring
- 34Peri-Transition Anticoagulant Review
- 35Glycemic Targets And Deintensification
- 36Insulin And Noninsulin Safety
- 37Statin Benefit In Older Adults
Neuropsychiatric Pain Therapy
Common geriatric decisions in dementia, mood disorders, sleep, pain, and neurologic pharmacotherapy with strong focus on CNS adverse effects and function.
- 38Cognitive Enhancer Use
- 39Delirium Medication Contributors
- 40Behavioral Symptom Drug Risks
- 41Antidepressant Selection In Aging
- 42Benzodiazepine And Z-Drug Risks
- 43Psychotropic Monitoring And Tapering
- 44Analgesic Selection In Older Adults
- 45Opioid Risk Mitigation
- 46Parkinsonism Seizure And Tremor
Infectious Renal GI Therapy
Applied therapeutic decisions in infections, renal dosing, pulmonary disease, bone health, and gastrointestinal or genitourinary disorders common in older adults.
- 47UTI And Pneumonia Pharmacotherapy
- 48Renal-Adjusted Antimicrobial Dosing
- 49C Diff And ADE Prevention
- 50COPD And Inhaler Optimization
- 51Osteoporosis And Fracture Prevention
- 52Thyroid Therapy In Aging
- 53Constipation And Bowel Regimens
- 54Acid Suppression And GI Risk
- 55Urinary Symptoms And Anticholinergics
Medication Safety Monitoring
Adverse drug event prevention, interaction management, monitoring design, and adherence support for older adults receiving complex medication regimens.
- 56Falls Sedation And Orthostasis
- 57Bleeding Hypoglycemia And AKI
- 58High-Risk Interaction Patterns
- 59Endpoints And Target Selection
- 60Lab And Symptom Follow-Up
- 61Adherence Barrier Assessment
- 62Comfort-Focused Medication Goals
- 63Deprescribing Near End Of Life
- 64Symptom Medication Safety
Transitions Ethics Calculations
Practice-based content for care transitions, quality frameworks, ethics, regulations, informatics, and applied dosing calculations relevant to BCGP preparation.
- 65Medication Reconciliation Process
- 66Post-Discharge Medication Hazards
- 67Long-Term Care Medication Systems
- 68Autonomy Surrogates And Advocacy
- 69Quality Measures And Regulations
- 70Clinical Informatics And MUE
- 71Research Statistics And Economics
- 72Cockcroft-Gault And Renal Dosing
- 73Dose Conversions And Tapers
- 74Regimen Feasibility Calculations


